ConductScience.org, home

Paper12880

Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.

Mehta J and 1 other. Circulation, 1977. Cited by 115 papers, by iCite.

Cite this record

ConductScience Library. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects. Papers, record 12880. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12880

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
PubMed
Journal
Circulation
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
6.58
iCite
Revised in PubMed
2019-06-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mehta JJ
2Cohn JNJ N

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic alpha-AntagonistsMajor topic
Adrenergic beta-AntagonistsMajor topic
EthanolaminesMajor topic
HemodynamicsMajor topic
HypertensionMajor topic
LabetalolMajor topic
Adult
Amyl Nitrite
Blood Pressure
Cardiac Output
Clinical Trials as Topic
Dose-Response Relationship, Drug
Heart Rate
Humans
Isoproterenol
Male
Middle Aged
Phenylephrine
Physical Exertion
Renin
Valsalva Maneuver
Vascular Resistance

Source PubMed

Download CSV of topics

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
32709242Retrospective evaluation of labetalol as antihypertensive agent in dogs.BMC Vet Res2020https://conductscience.org/library/papers/32709242PubMed
27042322Maternal ethnicity and its impact on the haemodynamic and blood pressure response to labetalol for the treatment of antenatal hypertension.Open Heart2016https://conductscience.org/library/papers/27042322PubMed
7428793Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7428793PubMed
7374093Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension.Klin Wochenschr1980https://conductscience.org/library/papers/7374093PubMed
7371699Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7371699PubMed
7308279The electrophysiological effects of intravenous labetalol in man.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7308279PubMed
7093104The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093104PubMed
7093099A review of the haemodynamic effects of labetalol in man.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093099PubMed
7093094Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093094PubMed
7093092Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093092PubMed
7082539Rapid reduction of blood pressure with acute oral labetalol.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7082539PubMed
7046773Response of the systemic pulmonary circulation to labetalol at rest and during exercise.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7046773PubMed
6511284Labetolol in patients with hypertension and varying degrees of renal impairment.Ir J Med Sci1984https://conductscience.org/library/papers/6511284PubMed
6386022Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6386022PubMed
6370541Clinical pharmacokinetics of labetalol.Clin Pharmacokinet1984https://conductscience.org/library/papers/6370541PubMed
6310204Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.Klin Wochenschr1983https://conductscience.org/library/papers/6310204PubMed
6151890Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.Drugs1984https://conductscience.org/library/papers/6151890PubMed
6151889Pharmacology of combined alpha-beta-blockade. I.Drugs1984https://conductscience.org/library/papers/6151889PubMed
6127131The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues.Br J Pharmacol1982https://conductscience.org/library/papers/6127131PubMed
6124265Comparison of labetalol with other anti-hypertensive drugs.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6124265PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12880

GET https://conductscience.org/api/papers/v1/12880/cited_by?page=2